VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $207,000 | +10.1% | 30,590 | -28.2% | 0.02% | +6.2% |
| Q1 2018 | $188,000 | -89.4% | 42,590 | -87.5% | 0.02% | -78.1% |
| Q4 2017 | $1,770,000 | -34.9% | 341,460 | -18.6% | 0.07% | -28.4% |
| Q3 2017 | $2,718,000 | -8.5% | 419,457 | -14.7% | 0.10% | -7.3% |
| Q2 2017 | $2,969,000 | +7.0% | 491,963 | +1.1% | 0.11% | -4.3% |
| Q1 2017 | $2,774,000 | -55.1% | 486,752 | -57.0% | 0.12% | -48.2% |
| Q4 2016 | $6,173,000 | -33.1% | 1,133,161 | -7.9% | 0.22% | -46.2% |
| Q3 2016 | $9,231,000 | -20.0% | 1,230,799 | -10.0% | 0.41% | -29.5% |
| Q2 2016 | $11,539,000 | -47.4% | 1,367,716 | -40.8% | 0.59% | -59.4% |
| Q1 2016 | $21,956,000 | +14.9% | 2,312,040 | +34.5% | 1.44% | +35.5% |
| Q4 2015 | $19,110,000 | – | 1,718,867 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |